PE
1993
$2 000 M
Dallas, Texas, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Trinity Hunt Partners is a growth-oriented private equity firm with over $2.3 billion of assets under management focused on partnering with business owners to build world-class companies within business and consumer services sectors. Since we were founded in 1993, our firm has earned a reputation for providing the strategic, operational, and financial expertise to take entrepreneurial services companies to the next level.
Trinity Hunt has invested in 35+ platform companies over the past 20 years. Our proven value creation process accelerates growth by providing our companies with the right resources, talent, and strategic guidance to materially scale organically and via acquisitions. We build relationships with exceptional management teams that share our passion for growing businesses based on trust, transparency, and respect. We are proud to have been consistently named a Top 50 Founder-Friendly Private Equity Firm by Inc. Magazine for the past five years. In 2023, Trinity Hunt ranked No. 6 amongst U.S. firms on the inaugural HEC-Dow Jones Best Performing Small-Cap Private Equity Firms ranking.
For more information or to submit an investment proposal, please visit our website at www.trinityhunt.com.
Industry
Region of investment
Trinity Hunt Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Trinity Hunt Partners IV L.P
|
Private Equity (PE)
|
Healthcare Services
Marketing and Advertising
Real Estate
Energy
LegalTech
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$211 M
|
September 2013
|
|
Trinity Hunt Partners VI
|
Private Equity (PE)
|
Healthcare Services
Marketing and Advertising
Real Estate
LegalTech
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$460 M
|
September 2021
|
|
Trinity Hunt Partners VII
|
Private Equity (PE)
|
Healthcare Services
Marketing and Advertising
Real Estate
Energy
LegalTech
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$700 M
|
February 2024
|